Radiation Therapy Clinical Trial
Official title:
Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer
Investigators used in-house-designed radiotherapy red and green light markers to distinguish individual measures after the provision of the initial nursing care to participants, added a homemade health education leaflet to collect data via actual observation, and counted the disappearance or fading of participants' body markers
From January 1, 2023 to June 30, 2023, a total of 200 participants were enrolled and undergoing radiation therapy. Inclusion Criteria: clear consciousness who could understand and comprehend Mandarin Chinese. Exclusion Criteria: patients with impaired consciousness or decreased cognitive abilities. Investigators proposed a set of strategic initiatives : 1. Consistent Schedule for the Replacement of Positioning Line Pens: Consistent Schedule for the Replacement of Positioning Line Pens: Investigators recommend implementing a standardized replacement schedule for positioning line pens, with replacement performed after every 50 uses. 2. Tailored Educational Content: Investigators created personalized educational content tailored to each patient's educational background. This approach ensures that participants can easily understand their treatment plan. 3. Hypoallergenic Adhesive Patches: Investigators offered a variety of hypoallergenic adhesive patches, catering to the skin characteristics of individual participants. 4. Enriched Treatment Care Platform: Investigators commitment extended to creating a comprehensive treatment care platform, which provided guidance on positioning line usage, interactive community features, and practical information. 5. Participants with BMI > 25 and an education level of high school or below, without specific caregivers, were identified by placing a red dot on the treatment record and on the patient's happiness card. Patients with BMI < 25 and an education level of high school or above, with specific caregivers, were identified by placing a green dot on their records. 6. After implementing the red-green light differentiation for radiation therapy and individual interventions, educational pamphlets prepared in-house were added, to assess the maintenance status of the positioning marks. The number of times the surface marks disappeared or faded during treatment was recorded on the day the participants completed treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04324645 -
Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
|
||
| Completed |
NCT04776083 -
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
|
Phase 3 | |
| Completed |
NCT01635270 -
Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma
|
Phase 2 | |
| Terminated |
NCT03724422 -
HO Prophylaxis Therapy for Distal Humerus Fractures
|
N/A | |
| Recruiting |
NCT03731130 -
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
|
||
| Recruiting |
NCT04983095 -
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT05721053 -
Improving Outcomes for Older Adults Undergoing Radiation Therapy
|
||
| Active, not recruiting |
NCT04764227 -
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
|
Phase 2 | |
| Not yet recruiting |
NCT05821452 -
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
|
Phase 2 | |
| Recruiting |
NCT05335148 -
Study to Evaluate the Safety of Colchicine
|
Phase 1 | |
| Recruiting |
NCT04362306 -
Radiation Oncology Patient Medical Physics Intervention Study
|
N/A | |
| Completed |
NCT01917890 -
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer
|
N/A | |
| Not yet recruiting |
NCT05648253 -
Hyivy Device in Post-radiation Patients
|
N/A | |
| Completed |
NCT03235427 -
The CAROLE (CArdiac Related Oncologic Late Effects) Study
|
||
| Recruiting |
NCT03142425 -
Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy
|
||
| Recruiting |
NCT05406063 -
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases
|
N/A | |
| Recruiting |
NCT03213925 -
Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT03071289 -
A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer
|
Phase 3 | |
| Recruiting |
NCT06128863 -
Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
|
Phase 2 | |
| Recruiting |
NCT05351294 -
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
|
Phase 3 |